Keyword Analysis & Research: cbdv for autism

clinicaltrials.gov

https://classic.clinicaltrials.gov/ct2/show/NCT03202303

DA: 25 PA: 23 MOZ Rank: 96

sciencedirect.com

https://www.sciencedirect.com/science/article/pii/S0163725821000802

Dr. Anukriti Pant

DA: 21 PA: 1 MOZ Rank: 66

herb.co

https://herb.co/learn/cbdvs-potential-for-autism-spectrum-disorder

WEBApr 8, 2024 · CBDV has shown great potential for treating symptoms of autism in preclinical research, and its safety and efficacy in children with autism is currently being examined in an ongoing clinical trial involving 100 children and adolescents.

DA: 79 PA: 61 MOZ Rank: 55

nature.com

https://www.nature.com/articles/s41398-019-0654-8

WEBPublished: 20 November 2019. Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism … Author: Charlotte Marie Pretzsch, Bogdan Voinescu, David John Lythgoe, Jamie Horder, Maria Andreina Mendez, ... Publish Year: 2019

Author: Charlotte Marie Pretzsch, Bogdan Voinescu, David John Lythgoe, Jamie Horder, Maria Andreina Mendez, ...

Publish Year: 2019

DA: 33 PA: 33 MOZ Rank: 39

norml.org

https://norml.org/news/2021/07/08/clinical-trial-single-dose-of-cbdv-modulates-atypical-brain-circuitry-in-patients-with-autism-spectrum-disorder/

WEBJul 8, 2021 · London, United Kingdom: The administration of the phytocannabinoid CBDV (cannabidivarin) modulates brain chemistry in autistic patients in a manner that is …

DA: 89 PA: 63 MOZ Rank: 19

sciencedirect.com

https://www.sciencedirect.com/science/article/pii/S0163725821000802

WEBOct 1, 2021 · CBDV and autism spectrum disorder. ASD refers to a group of neurodevelopmental disorders characterized by social and communication deficits … Author: Erica Zamberletti, Tiziana Rubino, Daniela Parolaro Publish Year: 2021

Author: Erica Zamberletti, Tiziana Rubino, Daniela Parolaro

Publish Year: 2021

DA: 11 PA: 47 MOZ Rank: 20

clinicaltrials.gov

https://classic.clinicaltrials.gov/ct2/show/NCT03202303

WEBJun 28, 2017 · CBDV, like VPA, is effective in the treatment of pediatric epilepsy, and ASD mouse models demonstrate potential mechanisms for treatment with CBDV, including … Allocation: Randomized Intervention Model: Parallel Assignment Estimated Enrollment : 100 participants Study Type : Interventional (Clinical Trial)

Allocation: Randomized

Intervention Model: Parallel Assignment

Estimated Enrollment : 100 participants

Study Type : Interventional (Clinical Trial)

DA: 2 PA: 5 MOZ Rank: 28

nih.gov

https://pubmed.ncbi.nlm.nih.gov/31748505/

WEBNov 20, 2019 · Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): a single dose trial during …

DA: 52 PA: 6 MOZ Rank: 22

sciencedirect.com

https://www.sciencedirect.com/science/article/pii/S0022395621001266

WEBMay 1, 2021 · Currently, trials involving cannabidiol (CBD), cannavidivarin (CBDV) and tetrahydrocannabinol (THC) in ASD are underway, but more research is needed to …

DA: 65 PA: 40 MOZ Rank: 44

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509693/

WEBAug 26, 2022 · This case study aims to demonstrate the use of cannabidiol (CBD) with low-dose tetrahydrocannabinol (THC) in managing symptoms associated with autism …

DA: 10 PA: 44 MOZ Rank: 29